Sounds about right. When management say they have a better product than MSB for AGVHD for a larger market and point out the difference in valuation then its worth taking note of. MSB post ph3 rejection at their lowest MC was around 200 to 300 million. That's still 5x from our current MC.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 352684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 49843 | 2 |
View Market Depth
| Last trade - 10.02am 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable